CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project has developed a diagnostic method for Dry Eye syndrome by measuring diadenosine tetraphosphate levels in tear samples. The technique aims to provide a reliable way to confirm the presence of the condition and monitor treatment effectiveness.
Scientists of our company invented a method for diagnosing and monitoring the effectiveness of dry-eye syndrome treatment.
The invention is related to a method for diagnosing the Dry Eye syndrome in patients and monitoring the effectiveness of the treatment, by measuring the concentration of a molecule called diadenosine tetraphosphate dinucleotide (Ap4A).
Ap4A is an intracellular signal molecule that is produced due to harsh environmental factors.
According to our studies published since 2002,…
OCUPHARM DIAGNOSTICS SL
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
